Global Markets and Technologies for Advanced Drug Delivery Systems

Global Markets and Technologies for Advanced Drug Delivery Systems

Report Scope:

This report aims to provide a comprehensive study of the global market for advance drug delivery systems (ADDS) and processes, both in terms of quantitative and qualitative data, to help people and companies develop business/growth strategies, assess the market landscape, analyze their position in the current marketplace and make informed business decisions regarding drug deliveries.

An in-depth analysis of the global ADDS market includes historical data and market projections on sales by product type, application, route of administration, drug mechanism and region. The analysis describes the different types of ADDS products (immediate drug release technology, modified drug release, advanced extended release drug delivery devices, and advanced delayed release and pulsatile release drug delivery systems) and their current and historical market revenues. This report also examines applications of ADDS (oncology, respiratory, inflammation and allergies, cardiovascular, ophthalmic, central nervous systems, hormone replacement therapy and gynecology, viral and bacterial diseases, diabetes, urology, gastrointestinal, dermatology and other therapeutics). This ADDS report also covers the route of administration of a drug delivery system as well as the source of a carrier mechanism for drug delivery.

The geographic scope of this study covers the U.S. and companies worldwide. The report identifies the main elements of advanced drug delivery products and trends in different industries.

Report Includes:

61 data tables and 61 additional tables

An up-to-date review and comprehensive analysis of the global markets for advanced drug delivery systems (ADDS) and processes

Analyses of the global market trends, with historic market revenue data for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027

Highlights of the current state of the advanced drug delivery market, recent technologies and platforms, and market participants

Estimation of the actual market size and market forecast for advanced drug delivery systems in value terms, and their corresponding market share analysis by technology, application, route of administration, vehicle/carrier of drugs mechanism, and geographic region

Assessment of major growth drivers, opportunities and challenges in this innovation driven market, with an update on the COVID-19 impact on advanced drug delivery systems

Review of patents and patent applications filed on drug delivery release mechanisms, clinical trial landscape, and emerging developments in the global market

Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues

Descriptive company profiles of the advanced drug-device combination products manufacturers, including 3M Co., Abbott Laboratories, B. Braun Melsungen AG, BD, Boston Scientific Corp., Medtronic, Sanofi S.A., and Terumo Corp.

Companies Mentioned

3m

Abbott Laboratories

Abbvie, Inc.

B. Braun Melsungen Ag

Bd

Boston Scientific Corp.

Cosmed Pharmaceutical Co., Ltd.

Johnson & Johnson Services Inc.

Medtronic Inc.

Sanofi S.A.

Smith & Nephew Plc

Stryker Corp.

Terumo Corp.